Resistant and refractory migraine – two different entities with different comorbidities? Results from the REFINE study

REFINE data indicate that individuals with ResM and RefM have a higher burden of comorbidities than those with NRNRM. It can be postulated that those comorbidities may have an impact on the progression of migraine from a form that is easy to treat to a form that is resistant or refractory to treatments. Longitudinal studies are needed to understand the direction of the association between ResM or RefM and those comorbidities and if proper treatment of comorbidities might help overcome treatment resistance or refractoriness.

Authors

Institutions

Publication Details

Journal
The Journal of Headache and Pain
Published
2024-12-03
DOI
https://doi.org/10.1186/s10194-024-01910-3
Citations
9
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
3.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Resistant and refractory migraine – two different entities with different comorbidities? Results from the REFINE study

Paolo Martelletti, Martina Gentile, William Wells-Gatnik, Loukia Apostolakopoulou et al.
9 citations
The Journal of Headache and Pain
Migraine and Headache Studies
3.47
article

Resistant and refractory migraine – two different entities with different comorbidities? Results from the REFINE study

Paolo Martelletti, Martina Gentile, William Wells-Gatnik, Loukia Apostolakopoulou, Isabel Pavão Martins, Ghaemeh Nabaei, Christian Lampl, Jurgita Vainauskienė, Jakob Paungarttner, Carine Rosignoli, Mark Braschinsky, Patricia Pozo‐Rosich, Margarita Sánchez del Río, Giancarla Iaccarino, Zaza Katsarava, Kristina Ryliškienė, Simona Sacco, Valeria Caponnetto, Albert Muñoz‐Vendrell, Raquel Gil‐Gouveia, Marta Waliszewska‐Prosół, Aynur Özge, Raffaele Ornello, Agnese Onofri, Sławomir Budrewićz, Fabrizio Vernieri, Maria Pia Prudenzano, M. Carnovali, Dimos D. Mitsikostas, Dilan Bayar Narin, S. Avaltroni, Olga Sved
article en
9 citations

Abstract

REFINE data indicate that individuals with ResM and RefM have a higher burden of comorbidities than those with NRNRM. It can be postulated that those comorbidities may have an impact on the progression of migraine from a form that is easy to treat to a form that is resistant or refractory to treatments. Longitudinal studies are needed to understand the direction of the association between ResM or RefM and those comorbidities and if proper treatment of comorbidities might help overcome treatment resistance or refractoriness.

The Journal of Headache and PainVol. 25(1)
University of Lisbon (PT), Università Campus Bio-Medico (IT), Vilnius University (LT), National and Kapodistrian University of Athens (GR), University of L'Aquila (IT), Wroclaw Medical University (PL), Shariati Hospital (IR), Vall d'Hebron Hospital Universitari (ES), Hospital da Luz (PT), Clinica Universidad de Navarra (ES), Eginition Hospital (GR), Mersin Üniversitesi (TR), University of Tartu (EE), University of Duisburg-Essen (DE), Tehran University of Medical Sciences (IR), Sapienza University of Rome (IT)
Openalex Percentile: Top 6%
Migraine and Headache Studies
3.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.